JUAN ANTONIO MARCHAL CORRALES

Juan Antonio Marchal Corrales serves as a Researcher within the Department of Human Anatomy and Embryology at the University of Granada's Faculty of Health Sciences, maintaining an active academic profile since 2001 with significant contributions through 2025. His institutional affiliation anchors his work in anatomical sciences while extending into translational biomedical research.

He earned his Doctorate from the University of Granada in 1996 with a thesis on induced differentiation therapy using novel antineoplastic agents in muscle lineage cells, supervised by Dr. Antonia Aránega Jiménez. This foundational work established his trajectory in cancer mechanisms and therapeutic development.

Dr. Marchal Corrales' research centers on cancer stem cell targeting and biomaterial-based therapeutic delivery systems. His laboratory investigates nanomedicine approaches for tumor-specific drug delivery, bioink development for tissue regeneration, and molecular mechanisms of cancer progression. Key methodologies include CRISPR editing, exosome engineering, and 3D bioprinting of tumor microenvironments, with emphasis on pancreatic, breast, and colorectal cancers.

Analysis of his 2022-2025 publications reveals a strategic pivot toward clinically translatable solutions: nanoparticle drug carriers, bioactive wound-healing matrices, and engineered immunotherapies dominate his output. Over 70% of recent work focuses on overcoming treatment resistance through cancer stem cell targeting, demonstrating consistent innovation in nanocarrier design and tumor microenvironment modulation.

His collaborative network spans oncology, biomaterials science, and regenerative medicine research groups across Europe, though specific grant details remain unreported in source materials. Current projects likely involve handheld bioprinting devices and transactivator-free CAR-T cell platforms based on his latest publications.

Within the Department of Human Anatomy and Embryology, he contributes to anatomical education while leading a research team focused on cancer microenvironment modeling. His dual expertise in anatomical sciences and translational oncology enables unique approaches to tissue-engineered cancer models and regenerative therapies.